Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,570 | -5,400 | -4,570 | -3,850 | -4,970 |
| Depreciation Amortization | 460 | 340 | 230 | 110 | 540 |
| Other Working Capital | 1,750 | 1,000 | 830 | 560 | 340 |
| Other Operating Activity | 3,450 | 3,260 | 2,910 | 2,870 | 1,510 |
| Operating Cash Flow | $-910 | $-800 | $-600 | $-310 | $-2,580 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -1 | 1 | 1 | -10 |
| Other Investing Activity | 42 | 41 | 49 | 49 | 0 |
| Investing Cash Flow | $40 | $40 | $50 | $50 | $-10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 910 | 750 | 510 | 230 | 2,680 |
| Financing Cash Flow | $910 | $750 | $510 | $230 | $2,680 |
| Exchange Rate Effect | -80 | -40 | -3 | -8 | -50 |
| Beginning Cash Position | 40 | 30 | 30 | 30 | 9 |
| End Cash Position | 4 | 0 | 0 | 6 | 40 |
| Net Cash Flow | $-30 | $-30 | $-30 | $-30 | $30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -910 | -800 | -600 | -310 | -2,580 |
| Free Cash Flow | -910 | -800 | -600 | -310 | -2,580 |